prednisone has been researched along with Bowel Diseases, Inflammatory in 63 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Clinical studies, registries, and case reports warn of the increased risk of infections, particularly opportunistic infections; however, already in the steroid monotherapy era, patients are at risk because it is accepted that a patient should be considered immunosuppressed when receiving a daily dose of 20 mg of prednisone for 2 weeks." | 4.88 | Risk of infection and prevention in pediatric patients with IBD: ESPGHAN IBD Porto Group commentary. ( de Ridder, L; Dias, JA; Escher, JC; Fell, J; Kolacek, S; Koletzko, S; Malmborg, P; Misak, Z; Rahier, JF; Veereman-Wauters, G; Veres, G, 2012) |
| "In April 1998, we began studying a new treatment regimen of peristomal pyoderma gangrenosum in which prednisone at a dose of 20 to 40 mg was administered systemically immediately after diagnosis." | 3.75 | Early diagnosis and early corticosteroid administration improves healing of peristomal pyoderma gangrenosum in inflammatory bowel disease. ( Fukushima, K; Funayama, Y; Kumagai, E; Sasaki, I; Takahashi, K, 2009) |
| "Type 1 refractory celiac disease is characterized by a normal intraepithelial lymphocyte population and type 2 is defined by the presence of an aberrant, clonal intraepithelial lymphocyte population." | 2.82 | AGA Clinical Practice Update on Management of Refractory Celiac Disease: Expert Review. ( Green, PHR; Ko, CW; Paski, S; Rubio-Tapia, A, 2022) |
| "Inflammation is a known pitfall of surveillance colonoscopy for inflammatory bowel disease (IBD) as it is difficult to differentiate between inflammation and true dysplasia." | 2.75 | A short course of corticosteroids prior to surveillance colonoscopy to decrease mucosal inflammation in inflammatory bowel disease patients: results from a randomized controlled trial. ( Baars, JE; Biermann, K; Kuipers, EJ; van der Woude, CJ; Vogelaar, L; Wolfhagen, FH, 2010) |
| "98 (1 kg(-1) x h(-1)) and the elimination half-life was 1." | 2.69 | Pharmacokinetics of intravenous methylprednisolone and oral prednisone in paediatric patients with inflammatory bowel disease during the acute phase and in remission. ( André, J; Cèzard, JP; Faure, C; Giraud, M; Jacqz-Aigrain, E; Munck, A; Pelatan, C, 1998) |
| "All but one Crohn's disease patient had relapsed by the end of the study at 6 months." | 2.69 | Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease. ( Fellermann, K; Hämling, J; Loeschke, K; Ludwig, D; Raedler, A; Stange, EF; Steffen, M; Stein, J, 2000) |
| "IBD increases the risk of pregnancy complications and adverse pregnancy outcomes." | 2.53 | Pregnancy and the Patient with Inflammatory Bowel Disease: Fertility, Treatment, Delivery, and Complications. ( Mahadevan, U; McConnell, RA, 2016) |
| " For patients with severe ulcerative colitis (UC), steroid dosing has been clarified, and a mega-analysis of steroid outcomes and toxicities has been reported." | 2.44 | Optimizing drug therapy in inflammatory bowel disease. ( Kornbluth, A; Swaminath, A, 2007) |
| "Although our prednisone dosing data could not be used as an accurate predictor of onset or joint distribution, there was a tendency for correlation between the average daily dosing and the ARCO score." | 2.43 | Inflammatory bowel disease related osteonecrosis: report of a large series with a review of the literature. ( Klingenstein, G; Kornbluth, A; Levy, RN; Present, DH; Shah, AK, 2005) |
| "Leukopenia and thrombocytopenia are observed mostly as a side effect of therapy, particularly with use of immunosuppressive drugs." | 2.40 | Inflammatory bowel disease and immune thrombocytopenic purpura: is there a correlation? ( Ammirati, M; Gruenstein, S; Kim, P; Korelitz, BI; Lipsey, L; Schwarz, S; Wisch, N; Zlatanic, J, 1997) |
| "Osteopenia or osteoporosis is common in patients with inflammatory bowel disease." | 2.40 | Prevention and treatment of osteoporosis in patients with inflammatory bowel disease. ( Sninsky, CA; Valentine, JF, 1999) |
| "Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) that compromise quality of life and may increase mortality." | 1.48 | Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease. ( Bewtra, M; Brensinger, CM; Chen, L; Curtis, JR; Lewis, JD; Mamtani, R; Osterman, MT; Roy, JA; Scott, FI; Xie, F; Yun, H, 2018) |
| "Primary sclerosing cholangitis (PSC) is a cholangiopathy-usually associated with inflammatory bowel disease-that leads to cirrhosis and liver failure." | 1.48 | Inflammatory Nodules Identify Steroid-Responsive Primary Sclerosing Cholangitis. ( Chen, JH; Deshpande, V, 2018) |
| "Sweet syndrome is a reactive, sterile, pustular dermatosis that occurs in association with infection, malignancy, or connective tissue disease or in response to the use of certain medications." | 1.35 | Sweet syndrome as a manifestation of azathioprine hypersensitivity. ( Brunner, KL; El-Azhary, RA; Gibson, LE, 2008) |
| "Abdominal pain was the most frequent symptom (100%), and hypoalbuminemia was the most frequent sign (70%)." | 1.32 | Gastrointestinal involvement in chronic granulomatous disease. ( Anaya-O'Brien, S; Anderson, VL; Darnell, DN; Gallin, JI; Hilligoss, DM; Holland, SM; Kleiner, DE; Malech, HL; Marciano, BE; Rosenzweig, SD, 2004) |
| " Three patients were treated with intravenous acyclovir with concomitant reduction of steroid dosage and recovered completely." | 1.30 | Management of varicella infection during the course of inflammatory bowel disease. ( Balasubramanian, S; Giannadaki, E; Greenstein, AJ; Manousos, ON; Mouzas, IA; Sachar, DB, 1997) |
| " Medical files were reviewed for adverse side effects: fever, pancreatitis, infections, gastrointestinal intolerance, aminotransferase level increase, leukopenia, and thrombocytopenia." | 1.30 | Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease. ( Kirschner, BS, 1998) |
| "Low bone density is frequent in both CD and UC, but apparently stable in CD." | 1.30 | Evolution of osteopenia in inflammatory bowel disease. ( Bottega, F; Dinca, M; Fries, W; Leone, L; Luisetto, G; Martin, A; Naccarato, R; Peccolo, F, 1999) |
| "Osteonecrosis is a serious complication of steroid therapy characterized by death of all the cellular elements of bone." | 1.28 | Steroid-related osteonecrosis in inflammatory bowel disease. ( Sparberg, M; Vakil, N, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (3.17) | 18.7374 |
| 1990's | 18 (28.57) | 18.2507 |
| 2000's | 19 (30.16) | 29.6817 |
| 2010's | 19 (30.16) | 24.3611 |
| 2020's | 5 (7.94) | 2.80 |
| Authors | Studies |
|---|---|
| Sleutjes, JAM | 1 |
| Roeters van Lennep, JE | 1 |
| van der Woude, CJ | 2 |
| de Vries, AC | 1 |
| Green, PHR | 1 |
| Paski, S | 1 |
| Ko, CW | 1 |
| Rubio-Tapia, A | 1 |
| Atherly, T | 1 |
| Rossi, G | 2 |
| White, R | 1 |
| Seo, YJ | 1 |
| Wang, C | 1 |
| Ackermann, M | 1 |
| Breuer, M | 1 |
| Allenspach, K | 1 |
| Mochel, JP | 1 |
| Jergens, AE | 3 |
| George, B | 1 |
| Tanveer, N | 1 |
| Valaparla, V | 1 |
| Boyars, M | 1 |
| Khan, N | 1 |
| Pernes, T | 1 |
| Weiss, A | 1 |
| Trivedi, C | 1 |
| Patel, M | 1 |
| Xie, D | 1 |
| Yang, YX | 1 |
| Lucafò, M | 1 |
| Bramuzzo, M | 1 |
| Selvestrel, D | 1 |
| Da Lozzo, P | 1 |
| Decorti, G | 1 |
| Stocco, G | 1 |
| Lewis, JD | 1 |
| Scott, FI | 1 |
| Brensinger, CM | 1 |
| Roy, JA | 1 |
| Osterman, MT | 1 |
| Mamtani, R | 1 |
| Bewtra, M | 1 |
| Chen, L | 1 |
| Yun, H | 1 |
| Xie, F | 1 |
| Curtis, JR | 1 |
| Chen, JH | 1 |
| Deshpande, V | 1 |
| Sullivan, SN | 1 |
| Ghaly, S | 1 |
| Targownik, LE | 1 |
| Benchimol, EI | 1 |
| Bernstein, CN | 1 |
| Singh, H | 1 |
| Lix, L | 1 |
| Tennakoon, A | 1 |
| Leung, S | 1 |
| Aviña, A | 1 |
| Coward, S | 1 |
| Jones, J | 1 |
| Kaplan, G | 1 |
| Murthy, SK | 1 |
| Nguyen, GC | 1 |
| Peña-Sánchez, JN | 1 |
| Levine, A | 1 |
| Turner, D | 1 |
| Pfeffer Gik, T | 1 |
| Amil Dias, J | 1 |
| Veres, G | 2 |
| Shaoul, R | 1 |
| Staiano, A | 1 |
| Escher, J | 1 |
| Kolho, KL | 1 |
| Paerregaard, A | 1 |
| Martin de Carpi, J | 1 |
| Veereman Wauters, G | 1 |
| Koletzko, S | 2 |
| Shevah, O | 1 |
| Finnby, L | 1 |
| Sladek, M | 1 |
| Demlova, R | 1 |
| Mrkvicova, M | 1 |
| Sterba, J | 1 |
| Bernatikova, H | 1 |
| Stary, J | 1 |
| Sukova, M | 1 |
| Mikuskova, A | 1 |
| Chocholova, A | 1 |
| Mladosievicova, B | 1 |
| Soltysova, A | 1 |
| Behulova, D | 1 |
| Pilatova, K | 1 |
| Zdrazilova-Dubska, L | 1 |
| Valik, D | 1 |
| Pengo, G | 1 |
| Caldin, M | 1 |
| Palumbo Piccionello, A | 1 |
| Steiner, JM | 2 |
| Cohen, ND | 1 |
| Suchodolski, JS | 2 |
| Gearry, RB | 1 |
| McConnell, RA | 1 |
| Mahadevan, U | 2 |
| Brady, MT | 1 |
| Patts, GJ | 1 |
| Rosen, A | 1 |
| Kasotakis, G | 1 |
| Siracuse, JJ | 1 |
| Sachs, T | 1 |
| Kuhnen, A | 1 |
| Kunitake, H | 1 |
| Vacas, AS | 1 |
| Torre, AC | 1 |
| Bollea-Garlatti, ML | 1 |
| Warley, F | 1 |
| Galimberti, RL | 1 |
| El-Azhary, RA | 1 |
| Brunner, KL | 1 |
| Gibson, LE | 1 |
| Sibai, M | 1 |
| El Moutawakil, B | 1 |
| Chourkani, N | 1 |
| Bourezgui, M | 1 |
| Rafai, MA | 1 |
| Slassi, I | 1 |
| Funayama, Y | 1 |
| Kumagai, E | 1 |
| Takahashi, K | 1 |
| Fukushima, K | 1 |
| Sasaki, I | 1 |
| He, C | 1 |
| Zhang, SL | 1 |
| Hu, CJ | 1 |
| Tong, DW | 1 |
| Li, YZ | 1 |
| Hou, JK | 1 |
| Velayos, F | 1 |
| Terrault, N | 1 |
| Baars, JE | 1 |
| Vogelaar, L | 1 |
| Wolfhagen, FH | 1 |
| Biermann, K | 1 |
| Kuipers, EJ | 1 |
| Veereman-Wauters, G | 1 |
| de Ridder, L | 1 |
| Kolacek, S | 1 |
| Fell, J | 1 |
| Malmborg, P | 1 |
| Dias, JA | 1 |
| Misak, Z | 1 |
| Rahier, JF | 1 |
| Escher, JC | 1 |
| Mrakotsky, C | 1 |
| Forbes, PW | 1 |
| Bernstein, JH | 1 |
| Grand, RJ | 2 |
| Bousvaros, A | 1 |
| Szigethy, E | 1 |
| Waber, DP | 1 |
| Heilmann, RM | 1 |
| Ackermann, MR | 1 |
| Barr, JW | 1 |
| Marciano, BE | 1 |
| Rosenzweig, SD | 1 |
| Kleiner, DE | 1 |
| Anderson, VL | 1 |
| Darnell, DN | 1 |
| Anaya-O'Brien, S | 1 |
| Hilligoss, DM | 1 |
| Malech, HL | 1 |
| Gallin, JI | 1 |
| Holland, SM | 1 |
| Klingenstein, G | 1 |
| Levy, RN | 1 |
| Kornbluth, A | 2 |
| Shah, AK | 1 |
| Present, DH | 2 |
| Caprilli, R | 1 |
| Angelucci, E | 1 |
| Cocco, A | 1 |
| Viscido, A | 1 |
| Annese, V | 1 |
| Ardizzone, S | 1 |
| Biancone, L | 1 |
| Castiglione, F | 1 |
| Cottone, M | 1 |
| Meucci, G | 1 |
| Paoluzi, P | 1 |
| Papi, C | 1 |
| Sturniolo, GC | 1 |
| Vecchi, M | 1 |
| Banerjee, S | 1 |
| Bishop, WP | 1 |
| Radhakrishnan, KR | 1 |
| Kay, M | 1 |
| Wyllie, R | 1 |
| Hashkes, PJ | 1 |
| Vavricka, SR | 1 |
| Dirnhofer, S | 1 |
| Degen, L | 1 |
| Swaminath, A | 1 |
| Cohran, VC | 1 |
| Griffiths, M | 1 |
| Heubi, JE | 1 |
| Motil, KJ | 1 |
| Davis-Kraft, L | 1 |
| Ferlic, LL | 1 |
| Smith, EO | 1 |
| Hayden, GM | 1 |
| Atlas, SA | 1 |
| Mouzas, IA | 1 |
| Greenstein, AJ | 1 |
| Giannadaki, E | 1 |
| Balasubramanian, S | 1 |
| Manousos, ON | 1 |
| Sachar, DB | 2 |
| Zlatanic, J | 1 |
| Korelitz, BI | 1 |
| Wisch, N | 1 |
| Kim, P | 1 |
| Ammirati, M | 1 |
| Schwarz, S | 1 |
| Gruenstein, S | 1 |
| Lipsey, L | 1 |
| Befeler, AS | 1 |
| Lissoos, TW | 1 |
| Schiano, TD | 1 |
| Conjeevaram, H | 1 |
| Dasgupta, KA | 1 |
| Millis, JM | 1 |
| Newell, KA | 1 |
| Thistlethwaite, JR | 1 |
| Baker, AL | 1 |
| Kruis, W | 1 |
| Pohl, C | 1 |
| McDonald, GB | 1 |
| Bouvier, M | 1 |
| Hockenbery, DM | 1 |
| Stern, JM | 1 |
| Gooley, T | 1 |
| Farrand, A | 1 |
| Murakami, C | 1 |
| Levine, DS | 1 |
| Kirschner, BS | 1 |
| Faure, C | 1 |
| André, J | 1 |
| Pelatan, C | 1 |
| Munck, A | 1 |
| Giraud, M | 1 |
| Cèzard, JP | 1 |
| Jacqz-Aigrain, E | 1 |
| Valentine, JF | 1 |
| Sninsky, CA | 1 |
| Dinca, M | 1 |
| Fries, W | 1 |
| Luisetto, G | 1 |
| Peccolo, F | 1 |
| Bottega, F | 1 |
| Leone, L | 1 |
| Naccarato, R | 1 |
| Martin, A | 1 |
| Tennenbaum, R | 1 |
| Marteau, P | 1 |
| Elefant, E | 1 |
| Rambaud, JC | 1 |
| Modigliani, R | 1 |
| Gendre, JP | 1 |
| Cosnes, J | 1 |
| Fellermann, K | 1 |
| Steffen, M | 1 |
| Stein, J | 1 |
| Raedler, A | 1 |
| Hämling, J | 1 |
| Ludwig, D | 1 |
| Loeschke, K | 1 |
| Stange, EF | 1 |
| Ang, YS | 1 |
| Mahmud, N | 1 |
| White, B | 1 |
| Byrne, M | 1 |
| Kelly, A | 1 |
| Lawler, M | 1 |
| McDonald, GS | 1 |
| Smith, OP | 1 |
| Keeling, PW | 1 |
| Maté-Jiménez, J | 1 |
| Hermida, C | 1 |
| Cantero-Perona, J | 1 |
| Moreno-Otero, R | 1 |
| Rikers, CH | 1 |
| Alberts, C | 1 |
| Jansen, HM | 1 |
| Maunder, RG | 1 |
| Esplen, MJ | 1 |
| Bonner, GF | 1 |
| Friedman, S | 1 |
| Mauras, N | 1 |
| George, D | 1 |
| Evans, J | 1 |
| Milov, D | 1 |
| Abrams, S | 1 |
| Rini, A | 1 |
| Welch, S | 1 |
| Haymond, MW | 1 |
| Isaza, R | 1 |
| Baker, B | 1 |
| Dunker, F | 1 |
| Kornbluth, AA | 1 |
| Salomon, P | 1 |
| Subramani, K | 1 |
| Kramer, A | 1 |
| Gray, CE | 1 |
| Chapman, ML | 1 |
| Wolfsen, HC | 1 |
| Brubacher, LL | 1 |
| Ng, CS | 1 |
| Kayne, AL | 1 |
| Kozarek, RA | 1 |
| Kushner, RF | 1 |
| Schoeller, DA | 1 |
| Spiro, HM | 1 |
| Hyams, JS | 1 |
| Treem, WR | 1 |
| Vakil, N | 1 |
| Sparberg, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Immunogenicity of Hepatitis A Vaccine in Patients With Inflammatory Bowel Disease[NCT01341808] | Phase 4 | 493 participants (Actual) | Interventional | 2011-04-30 | Completed | ||
| Natural History of Intestinal Inflammation in Patients With Primary Immune Dysregulations[NCT03278912] | 0 participants (Actual) | Observational | 2023-09-08 | Withdrawn (stopped due to Funding completed.) | |||
| A Randomized, Placebo-Controlled, Multi-Center Study of Oral Beclomethasone Dipropionate With Ten Days of Prednisone for Treatment of Gastrointestinal Graft Vs. Host Disease[NCT00233896] | Phase 3 | 130 participants | Interventional | 2001-07-31 | Completed | ||
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Safety and Efficacy of orBec® (Oral Beclomethasone 17,21-Dipropionate)in Conjunction With Ten Days of High-Dose Prednisone Therapy in the Treatment of Patients With Gastroin[NCT00926575] | Phase 3 | 140 participants (Actual) | Interventional | 2009-10-31 | Terminated (stopped due to An independent Data Safety Monitoring Board recommended the study be stopped due to futility) | ||
| Study of Pharmacokinetic Variability of Glucocorticoids in Children[NCT02252237] | 146 participants (Actual) | Observational | 2014-12-03 | Completed | |||
| Multicenter Study Evaluating the Persistence, Efficacy and Tolerability of Methotrexate in Inflammatory Bowel Disease Patients[NCT05927064] | 1,000 participants (Anticipated) | Observational | 2023-07-21 | Recruiting | |||
| Growth and the Effect of Genotropin in Chronically Ill Children With Juvenile Rheumatoid Arthritis and With Crohn's Disease[NCT00511329] | Phase 2/Phase 3 | 10 participants (Actual) | Interventional | 2007-08-31 | Terminated (stopped due to PI left the institution) | ||
| Effect of Increlex® on Children With Crohn Disease[NCT00764699] | Phase 2/Phase 3 | 3 participants (Actual) | Interventional | 2008-10-31 | Terminated (stopped due to PI left institution) | ||
| The Effects of Disease Activity on Resting Energy Expenditure in Subjects With Crohn's Disease: A Cross-sectional Study[NCT03054935] | 150 participants (Anticipated) | Observational | 2016-07-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 reviews available for prednisone and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
AGA Clinical Practice Update on Management of Refractory Celiac Disease: Expert Review.
Topics: Albumins; Atrophy; Budesonide; Celiac Disease; Enteropathy-Associated T-Cell Lymphoma; Glutens; Huma | 2022 |
Pregnancy and the Patient with Inflammatory Bowel Disease: Fertility, Treatment, Delivery, and Complications.
Topics: Adalimumab; Aminosalicylic Acids; Anti-Bacterial Agents; Antibodies, Monoclonal; Biological Products | 2016 |
Viral hepatitis and inflammatory bowel disease.
Topics: Alanine Transaminase; Antiviral Agents; Female; Hepatitis, Viral, Human; Humans; Immunosuppressive A | 2010 |
Risk of infection and prevention in pediatric patients with IBD: ESPGHAN IBD Porto Group commentary.
Topics: Antibodies, Monoclonal; Drug Therapy, Combination; Europe; Humans; Immunosuppressive Agents; Inflamm | 2012 |
Inflammatory bowel disease related osteonecrosis: report of a large series with a review of the literature.
Topics: Adult; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gluco | 2005 |
Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Drug Resistance; Drug Therapy, Comb | 2005 |
Optimizing drug therapy in inflammatory bowel disease.
Topics: Absorptiometry, Photon; Adalimumab; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal | 2007 |
Inflammatory bowel disease and immune thrombocytopenic purpura: is there a correlation?
Topics: Adolescent; Adult; Anemia; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Female; Hum | 1997 |
Prevention and treatment of osteoporosis in patients with inflammatory bowel disease.
Topics: Anti-Inflammatory Agents; Bone Density; Calcitonin; Calcium Carbonate; Diphosphonates; Exercise; Fem | 1999 |
ACTH-induced adrenal hemorrhage: a complication of therapy masquerading as an acute abdomen.
Topics: Abdomen, Acute; Adrenocorticotropic Hormone; Adult; Aminosalicylic Acids; Cortisone; Diagnosis, Diff | 1990 |
10 trials available for prednisone and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease.
Topics: Animals; Anti-Inflammatory Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Duodenum; Female; | 2014 |
A short course of corticosteroids prior to surveillance colonoscopy to decrease mucosal inflammation in inflammatory bowel disease patients: results from a randomized controlled trial.
Topics: Adult; Anti-Inflammatory Agents; Biopsy; Colitis, Ulcerative; Colonoscopy; Colorectal Neoplasms; Cro | 2010 |
Serum calprotectin concentrations in dogs with idiopathic inflammatory bowel disease.
Topics: Animals; Anti-Infective Agents; Biomarkers; C-Reactive Protein; Dog Diseases; Dogs; Drug Therapy, Co | 2012 |
Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized, controlled trial.
Topics: Administration, Oral; Adult; Aged; Beclomethasone; Female; Graft vs Host Disease; Humans; Inflammato | 1998 |
Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized, controlled trial.
Topics: Administration, Oral; Adult; Aged; Beclomethasone; Female; Graft vs Host Disease; Humans; Inflammato | 1998 |
Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized, controlled trial.
Topics: Administration, Oral; Adult; Aged; Beclomethasone; Female; Graft vs Host Disease; Humans; Inflammato | 1998 |
Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized, controlled trial.
Topics: Administration, Oral; Adult; Aged; Beclomethasone; Female; Graft vs Host Disease; Humans; Inflammato | 1998 |
Pharmacokinetics of intravenous methylprednisolone and oral prednisone in paediatric patients with inflammatory bowel disease during the acute phase and in remission.
Topics: Acute-Phase Reaction; Administration, Oral; Adolescent; Anti-Inflammatory Agents; Child; Child, Pres | 1998 |
Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease.
Topics: Adult; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunosuppressive Agents; Inflammatory Bo | 2000 |
Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Anticoagulants; Female; Heparin; Humans | 2000 |
6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Antimetabolites; Chi-Square Distribution; Drug Th | 2000 |
Supportive-expressive group psychotherapy for persons with inflammatory bowel disease.
Topics: Adaptation, Psychological; Adult; Anti-Inflammatory Agents; Antidepressive Agents; Anxiety; Benzodia | 2001 |
Resting and total energy expenditure in patients with inflammatory bowel disease.
Topics: Adult; Analysis of Variance; Anthropometry; Basal Metabolism; Body Weight; Energy Metabolism; Female | 1991 |
43 other studies available for prednisone and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Lipid Changes After Induction Therapy in Patients with Inflammatory Bowel Disease: Effect of Different Drug Classes and Inflammation.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Induction Chemotherapy; Inflammation; Inf | 2023 |
Glucocorticoid and dietary effects on mucosal microbiota in canine inflammatory bowel disease.
Topics: Animals; Bacteria; Cadherins; Demography; Diet; Dog Diseases; Dogs; Glucocorticoids; Inflammatory Bo | 2019 |
A Case of Pyoderma Gangrenosum of Head and Neck Mimicking Purulent Cellulitis.
Topics: Adult; Anti-Inflammatory Agents; Cellulitis; Diagnosis, Differential; Gastrointestinal Agents; Head; | 2021 |
Incidence of Infections and Malignancy Among Elderly Male Patients with IBD Exposed to Vedolizumab, Prednisone, and 5-ASA Medications: A Nationwide Retrospective Cohort Study.
Topics: Aged; Antibodies, Monoclonal, Humanized; Cohort Studies; Gastrointestinal Agents; Humans; Incidence; | 2021 |
Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel Disease.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Drug Resistance; Female; Humans; Immunosuppressive | 2021 |
Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Cardiovas | 2018 |
Inflammatory Nodules Identify Steroid-Responsive Primary Sclerosing Cholangitis.
Topics: Adolescent; Adult; Biopsy; Cholangitis, Sclerosing; Diagnosis, Differential; Female; Glucocorticoids | 2018 |
Bullous Pyoderma Gangrenosum and Inflammatory Bowel Disease.
Topics: Blister; Female; Humans; Inflammatory Bowel Diseases; Leg; Middle Aged; Prednisone; Pyoderma Gangren | 2018 |
What is in our treasure chest? Australian pharmaceutical benefits scheme availability and criteria for prescribing biologics.
Topics: Adalimumab; Antibodies, Monoclonal, Humanized; Australia; Azathioprine; Biological Factors; Drug App | 2018 |
Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study.
Topics: Adalimumab; Adult; Azathioprine; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Digestive Syste | 2019 |
Comparison of outcomes parameters for induction of remission in new onset pediatric Crohn's disease: evaluation of the porto IBD group "growth relapse and outcomes with therapy" (GROWTH CD) study.
Topics: Adolescent; Age of Onset; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Child; Co | 2014 |
Augmenting clinical interpretability of thiopurine methyltransferase laboratory evaluation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chromatography, High Press | 2014 |
Treat to target-what is realistic in Australian practice today?
Topics: Antibodies, Monoclonal, Humanized; Australia; Humans; Immunologic Factors; Inflammatory Bowel Diseas | 2016 |
Postoperative Venous Thromboembolism in Patients Undergoing Abdominal Surgery for IBD: A Common but Rarely Addressed Problem.
Topics: Adult; Anticoagulants; Colectomy; Colitis, Ulcerative; Colonic Pouches; Colostomy; Crohn Disease; Da | 2017 |
Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients.
Topics: Adalimumab; Adult; Age Factors; Aged; Arthritis, Rheumatoid; Cyclosporine; Dermatologic Agents; Etan | 2017 |
Sweet syndrome as a manifestation of azathioprine hypersensitivity.
Topics: Adult; Aged; Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Hypersensitivity; Humans; Immuno | 2008 |
[Neurological manifestations of chronic inflammatory bowel disease].
Topics: Adult; Anti-Inflammatory Agents; Brain; Demyelinating Autoimmune Diseases, CNS; Female; Humans; Infl | 2008 |
Early diagnosis and early corticosteroid administration improves healing of peristomal pyoderma gangrenosum in inflammatory bowel disease.
Topics: Adult; Early Diagnosis; Female; Glucocorticoids; Humans; Ileostomy; Inflammatory Bowel Diseases; Mal | 2009 |
Higher levels of CCL20 expression on peripheral blood mononuclear cells of chinese patients with inflammatory bowel disease.
Topics: Adult; Aged; Biomarkers; Biomarkers, Pharmacological; C-Reactive Protein; Chemokine CCL20; China; Di | 2010 |
Acute cognitive and behavioral effects of systemic corticosteroids in children treated for inflammatory bowel disease.
Topics: Adolescent; Adrenal Cortex Hormones; Analysis of Variance; Child; Child Behavior; Cognition; Cross-S | 2013 |
Gastrointestinal involvement in chronic granulomatous disease.
Topics: Abdominal Pain; Adolescent; Adult; Child; Child, Preschool; Colon; Constipation; Diarrhea; Female; G | 2004 |
Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Erythr | 2006 |
Wegener granulomatosis mimicking inflammatory bowel disease in a pediatric patient.
Topics: Abdominal Pain; Adolescent; Antibodies, Antineutrophil Cytoplasmic; Appendectomy; Azathioprine; Biop | 2006 |
Polyarteritis nodosa mimicking inflammatory bowel disease.
Topics: Biopsy; Colonoscopy; Cyclophosphamide; Diagnosis, Differential; Female; Glucocorticoids; Humans; Imm | 2007 |
Bone mineral density in children exposed to chronic glucocorticoid therapy.
Topics: Adolescent; Arthritis, Juvenile; Bone Density; Calcium, Dietary; Child; Child, Preschool; Cross-Sect | 2008 |
Growth failure in children with inflammatory bowel disease: a prospective study.
Topics: Administration, Oral; Adolescent; Body Height; Body Weight; Child; Female; Growth Disorders; Humans; | 1993 |
Strongyloidiasis masquerading as inflammatory bowel disease in a patient with lupus erythematosis: a case report.
Topics: Animals; Biopsy; Diagnosis, Differential; Female; Humans; Inflammatory Bowel Diseases; Intestinal Mu | 1995 |
Management of varicella infection during the course of inflammatory bowel disease.
Topics: Acyclovir; Adult; Anti-Inflammatory Agents; Antiviral Agents; Azathioprine; Cause of Death; Cephalex | 1997 |
Clinical course and management of inflammatory bowel disease after liver transplantation.
Topics: Adult; Aminosalicylic Acids; Cholangitis, Sclerosing; Colectomy; Colitis, Ulcerative; Crohn Disease; | 1998 |
[Recurrence-preventive (remission preserving) therapy of chronic inflammatory bowel diseases].
Topics: Anti-Inflammatory Agents; Antimetabolites; Azathioprine; Chronic Disease; Colitis, Ulcerative; Crohn | 1998 |
Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Databases as Topic; Drug Hypersensitivity; | 1998 |
Evolution of osteopenia in inflammatory bowel disease.
Topics: Absorptiometry, Photon; Adolescent; Adult; Aged; Body Mass Index; Bone Density; Bone Diseases, Metab | 1999 |
[Pregnancy outcome in inflammatory bowel diseases].
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Female; | 1999 |
[Non-specific inflammation of the respiratory tract in a female patient with inflammatory bowel disease and osteoporosis].
Topics: Administration, Inhalation; Adult; Anti-Inflammatory Agents; Asthma; Colectomy; Contraindications; D | 2001 |
Fractures in adults on systemic steroid therapy: which prophylaxis?
Topics: Arthritis, Rheumatoid; Asthma; Bone Density; Calcitonin; Calcium; Clinical Trials as Topic; Diphosph | 1999 |
Managing the glucocorticoid dependent inflammatory bowel disease patient.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antimetabolites; Gastrointestinal A | 2001 |
Management of inflammatory bowel disease during pregnancy and nursing.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Breast Feeding; Ce | 2001 |
Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study.
Topics: Adolescent; Amino Acids; Body Composition; Bone and Bones; Calcium; Carbohydrate Metabolism; Child; | 2002 |
Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study.
Topics: Adolescent; Amino Acids; Body Composition; Bone and Bones; Calcium; Carbohydrate Metabolism; Child; | 2002 |
Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study.
Topics: Adolescent; Amino Acids; Body Composition; Bone and Bones; Calcium; Carbohydrate Metabolism; Child; | 2002 |
Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study.
Topics: Adolescent; Amino Acids; Body Composition; Bone and Bones; Calcium; Carbohydrate Metabolism; Child; | 2002 |
Medical management of inflammatory bowel disease in a spider monkey.
Topics: Animals; Cebidae; Diarrhea; Electrolytes; Female; Inflammatory Bowel Diseases; Monkey Diseases; Pred | 1992 |
Refractory parastomal ulcers: a multidisciplinary approach.
Topics: Chronic Disease; Colonic Neoplasms; Enterostomy; Female; Humans; Inflammatory Bowel Diseases; Male; | 1990 |
Six physicians with inflammatory bowel disease.
Topics: Attitude to Health; Denial, Psychological; Female; Guilt; Hostility; Humans; Inflammatory Bowel Dise | 1990 |
Cyclosporine treatment of fulminant colitis.
Topics: Acute Disease; Adolescent; Child; Colitis; Cyclosporins; Female; Humans; Inflammatory Bowel Diseases | 1989 |
Steroid-related osteonecrosis in inflammatory bowel disease.
Topics: Adult; Female; Humans; Inflammatory Bowel Diseases; Male; Osteonecrosis; Prednisone; Retrospective S | 1989 |